Head-to-Head Comparison of Biologics vs Ustekinumab for Crohn's Disease: A Systematic Review of Efficacy

被引：0
|
作者：
Pulakurthi, Yashwitha Sai [1 ]
Okwesili, Byron [1 ]
Jagirdhar, Gowthami Sai Kogilathota [1 ]
Ginjupalli, Manasa [2 ]
Vikash, Fnu [3 ]
Kumar, Vikash [4 ]
Bains, Yatinder [1 ]
Shah, Mehul [1 ]
机构：
[1] St Michaels Hosp, Newark, NJ USA
[2] Brooklyn Hosp Ctr, New York, NY USA
[3] Albert Einstein Coll Med, New York, NY USA
[4] Creighton Univ, Sch Med, Brooklyn, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034024.66708.fb
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1164
引用
收藏
页码：S826 / S827
页数：2
相关论文
共 50 条
  • [1] A Head-to-Head Comparison Ustekinumab as Second-Line Therapy in Moderate to Severely Active Crohn's Disease
    Roshanov, Pavel s.
    Khanna, Reena
    GASTROENTEROLOGY, 2025, 168 (03) : 624 - 624
  • [2] Head-to-Head Comparison Between Adalimumab and Infliximab in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis
    Aboursheid, Tarek
    Beran, Azizullah
    Hijazi, Mohamad
    Albuni, Mhd K.
    Sawaf, Bisher
    Abdeljawad, Khaled
    Rahima, M. Kenan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S893 - S893
  • [3] Head-to-head biologic therapy in Crohn's disease
    Chapman, Thomas P.
    Satsangi, Jack
    LANCET, 2022, 399 (10342): : 2169 - 2171
  • [4] Efficacy of risankizumab versus ustekinumab by baseline Crohn's Disease location: post-hoc analysis of the SEQUENCE head-to-head trial
    Peyrin-Biroulet, L.
    Colombel, J. F.
    D'Haens, G.
    Dubinsky, M.
    Cao, Q.
    Kligys, K.
    Garrison, A.
    Huang, X.
    Neimark, E.
    Anschutz, T.
    Crowley, J.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I104 - I105
  • [5] First-line biological ustekinumab in a head-to-head comparison
    Warpakowski, Andrea
    VISCERAL MEDICINE, 2021, 37 (05) : 452 - 453
  • [6] Head-to-head comparison of the costs of atypical antipsychotics - A systematic review
    Barbui, C
    Lintas, C
    Percudani, M
    CNS DRUGS, 2005, 19 (11) : 935 - 950
  • [7] Head-To-Head Comparison of the Costs of Atypical AntipsychoticsA Systematic Review
    Corrado Barbui
    Camilla Lintas
    Mauro Percudani
    CNS Drugs, 2005, 19 : 935 - 950
  • [8] A recent Head-to-Head Study evaluates Efficacy and Safety of Ustekinumab versus Adalimumab
    不详
    VISCERAL MEDICINE, 2018, 34 (04) : 319 - 319
  • [9] Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
    Guglielmo, Priscilla
    Alongi, Pierpaolo
    Baratto, Lucia
    Abenavoli, Elisabetta
    Buschiazzo, Ambra
    Celesti, Greta
    Conte, Miriam
    Filice, Rossella
    Gorica, Joana
    Jonghi-Lavarini, Lorenzo
    Lanzafame, Helena
    Laudicella, Riccardo
    Librando, Maria
    Linguanti, Flavia
    Mattana, Francesco
    Miceli, Alberto
    Olivari, Laura
    Piscopo, Leandra
    Romagnolo, Cinzia
    Santo, Giulia
    Vento, Antonio
    Volpe, Fabio
    Evangelista, Laura
    LIFE-BASEL, 2023, 13 (09):
  • [10] First Head-to-Head Study in Crohn's Disease supports the Use of Ustekinumab as a First-line Biological in Biological-naive Patients
    不详
    VISCERAL MEDICINE, 2021, 37 (04) : 326 - 326
12345